Product Image

Ginkgo

Oregon's Wild Harvest
4.8
★ ★ ★ ★ ★
(49 ratings)
Ginkgo
Product Image
Score71
A practical ginkgo serving for circulation-related cognitive use. The extract names flavone glycosides and terpene lactones, but their percentages and a purity limit are missing.
How scoring works
Quantity:90 Capsule(s) • (30 servings)
Goals:
Cognitive Support
Brain Health
Mental Focus
Productivity Boost

Score 71

A practical ginkgo serving for circulation-related cognitive use. The extract names flavone glycosides and terpene lactones, but their percentages and a purity limit are missing.
How scoring works
$31.16($1.03 per serving)
Vitacost
$ 31.16
Pure Formulas
$ 31.16
iHerb
$ 31.16
Report prices

Analysis

The three-capsule serving provides 180 mg ginkgo extract, targeting cerebral and peripheral circulation. The amount fits common daily cognitive use.

Ginkgo may support selected memory, focus, or circulation-related outcomes, but it is not a broad nootropic. Its vision relevance is also narrow because it does not supply lutein, zeaxanthin, retinal omega-3 fats, or antioxidant minerals.

The extract names flavone glycosides and terpene lactones, but their percentages and a purity limit are missing. An additional 1,140 mg organic leaf increases raw material without confirming standardized potency. The focused format is easy to understand, though extract quality matters more than raw leaf weight or package size.

Who is it for
  • Adults seeking focused ginkgo supplementation
  • Users interested in circulation-related cognitive support
  • People who prefer a three-capsule serving
Best for
  • Targeted ginkgo use
  • Memory and focus routines in suitable adults
  • Users seeking a single-botanical formula

Pros

  • Ginkgo amount is clearly listed
  • Focused formula is easy to assess
  • Amount fits common daily use
  • Stimulant-free botanical

Cons

  • Does not provide broad cognitive pathway coverage
  • Not a complete vision formula
  • Extract standardization is incomplete
  • An additional 1,140 mg organic leaf increases raw material without confirming standardized potency.

Warnings

  • Ginkgo may add to warfarin, direct oral anticoagulants, aspirin, or other antiplatelet effects and increase bleeding risk
  • Stop ginkgo before surgery or an invasive procedure when directed by the treating clinician because of its bleeding effects
  • Ginkgo may cause headache, dizziness, or digestive upset in sensitive users

Nutrient quality

83 Highest impact

A meaningful extract amount and named marker groups support the intended use. Large unstandardized leaf content and missing marker percentages limit dose precision.

.

Ingredient transparency

80 High impact

Active amounts and marker names are disclosed without a hidden blend. Marker percentages, daily-use directions, and non-active ingredients remain unavailable.

.

Customer satisfaction

61 Moderate impact

The available rating is strong and the sample is small. Detailed feedback was not supplied, so repeated complaints and alignment with the intended use remain uncertain.

.

Value for money

54 Moderate impact

The short supply is expensive despite a meaningful extract amount. Unstandardized whole leaf and missing marker percentages weaken competitive value.

.
Report analysis

Goals

Cognitive Support
Cognitive Support
Impact
High effect
B+ Goal FitB- Strength of SupportD+ CoverageA- Formula Quality

Ginkgo directly targets cerebral circulation and has human evidence for some memory outcomes. The extract amount is meaningful, but missing marker percentages prevent confirmation of clinical standardization.

The formula provides focused depth in one cognitive pathway rather than broad coverage. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 87 studies
Brain Health
Brain Health
Impact
High effect
B- Goal FitC+ Strength of SupportD+ CoverageA- Formula Quality

Ginkgo is directly relevant to cerebral circulation and may support cognition in selected users, particularly older adults. The extract amount is useful and fully disclosed, but missing marker percentages prevent confirmation that it matches clinically studied preparations.

A single-ingredient design gives the formula clear focus and avoids dilution. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Mental Focus
Mental Clarity
Mental Focus
Impact
High effect
C+ Goal FitB- Strength of SupportD- CoverageA- Formula Quality

The ginkgo extract amount falls within commonly studied daily ranges and may support attention or processing in selected users. Flavone glycosides and terpene lactones are named, which is more informative than a plain leaf powder alone.

The label omits active-marker percentages, so it cannot be matched confidently to standardized clinical extracts. Ginkgo may increase bleeding risk when combined with anticoagulant medicines such as warfarin or antiplatelet medicines such as clopidogrel.

Study evidence
Ginkgo Supportive 28 studies
Productivity Boost
Productivity Boost
Impact
High effect
C+ Goal FitC+ Strength of SupportD+ CoverageB+ Formula Quality

Ginkgo provides a direct cognitive-support mechanism that may help attention in some contexts. Human evidence is mixed and most applicable to standardized extracts rather than unspecified preparations.

The extract amount is within a commonly studied daily range. Only circulation and cognitive support are addressed without acute alertness or stress adaptation.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Vision Support
Eye Circulation
Vision Support
Impact
Moderate effect
D- Goal FitC+ Strength of SupportD- CoverageB+ Formula Quality

Ginkgo may support ocular blood flow, but evidence for meaningful vision outcomes is limited and less established than macular carotenoids or AREDS2 nutrients. The extract amount is useful, while missing marker percentages prevent confirmation of standardized potency.

The focused formula provides one circulation-related pathway without antioxidant-mineral or retinal-lipid support. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
organic Ginkgo
1140 mg
Ginkgo leaf powdered extract (Flavone Glycosides, Terpene Lactones)
 180 mg
Gluten Free Adults 18–50 Dairy Free Women Organic
Report overview
Ginkgo · 1140 mg OverallScore48
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value
Flavone glycoside and terpene lactone markers are named, but their percentages are not stated. 180 mg falls within the effective daily extract range. Missing marker percentages prevent a reliable standardized-dose cost comparison. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.
View ingredientView products
Loading alternative details
83 Performance

Ginkgold 120 mg

Nature's Way
A 120 mg Ginkgold extract identified by flavone glycosides and terpene lactones offers a focused, substantial ginkgo dose. Exact marker percentages and a ginkgolic-acid limit are not supplied, so extract characterization is still incomplete.
84 Performance

Ginkgo Biloba Phytosome 60 mg

Natural Factors HerbalFactors
A 60 mg Ginkgoselect phytosome uses a distinct delivery format that may suit someone prioritizing a compact dose. The supplied label does not state flavone, terpene, or ginkgolic-acid details, which limits direct potency comparison.
84 Performance

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A concise 120 mg extract identified by flavone glycosides and terpene lactones provides stronger dose depth than many 40 mg or 60 mg formulas. Marker percentages and a ginkgolic-acid limit are not shown, but the simple formula supports clear comparison.
83 Budget

Ginkgo Biloba 60 mg

NOW
A lower recurring cost provides a 60 mg extract identified by ginkgo flavone glycosides and terpene lactones plus 200 mg of ginkgo powder. Marker percentages are not stated, but the added powder and long supply provide useful depth for the cost.
84 Budget

Ginkgo Biloba Certified Extract 120 mg

Life Extension
A lower recurring cost provides 120 mg of ginkgo with flavone glycosides, terpene lactones, and a stated low ginkgolic-acid limit. Exact marker percentages are not shown, while the impurity limit and long supply improve practical quality.
83 Budget

Ginkgo Biloba 60 mg

Swanson Superior Herbs
A lower recurring cost provides a branded 60 mg GinkgoSelect extract identified by flavone glycosides and terpene lactones. The marker percentages are missing, but the focused formula remains easy to assess and inexpensive to use.
84 Value

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones combines a substantial dose with a long supply. The missing marker percentages and ginkgolic-acid limit are the main quality gaps.
80 Value

Double Strength Ginkgo Biloba 120 mg

NOW
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones is paired with 250 mg of eleuthero at a low serving cost. Exact ginkgo marker percentages are absent, and eleuthero makes the formula less focused than a single-ingredient option.
80 Value

Ginkgo-24 120 mg

Source Naturals
A lower serving cost than the original accompanies the following trade-off: a simple 120 mg ginkgo extract identifies both flavone glycosides and terpene lactones at a moderate serving cost. The label does not state exact marker percentages or a ginkgolic-acid limit.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health Cognitive Support forGinkgo
  2. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  4. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  5. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  6. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  7. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  8. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  9. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  10. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  11. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  12. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  13. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  14. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  15. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  16. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  17. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  18. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  19. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  20. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  21. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  22. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  23. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  24. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  25. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  26. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  27. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo